Skip to main content
Premium Trial:

Request an Annual Quote

Aventis Subscribes to Inpharmatica s Biopendium Database

NEW YORK, Nov. 25 (GenomeWeb News) - Inpharmatica said today that Aventis has entered into a non-exclusive multi-user agreement for its Biopendium proteome annotation database.

Financial terms of the agreement were not disclosed.

Inpharmatica said that Biopendium would be installed on site at Aventis.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.